SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : BSD Medical (Long Term Investment Oriented) -- Ignore unavailable to you. Want to Upgrade?


To: nothingoutofbounds who wrote (110)2/12/2013 11:12:09 AM
From: pleonastic1 Recommendation  Read Replies (1) | Respond to of 178
 
>I 100% believe that the huge money will be here after the 6th quarter of triple digit growth, but I also believe that the early birds will begin showing up around 3. Without specific numbers, I believe we have 2 in a row... and any quarterly or monthly YOY update would probably be enough confirmation to signal early bird investors to accumulate. <

Spoken by a very-early bird! I'm one of those, too. It has taken a long time for electrohyperthermia and heat-ablation to be proven (to doctors, that is -- I think engineers are more apt to clearly see the potential, ahead of massive clinical proof). But these therapies are now moving into main-stream practice.

I hope you are right about "investors". I don't see BSD Medical as a particularly good short-term trading stock -- relative to its potential for long-term oriented buyers. Anyway, I get short-tempered with "daytraders", as I think they are basically spastic nuts -- re BSDM, at least.

BTW, I'm presently trying to become acquainted enough with a recent scientific article (Science, 1 Feb 2013) to be able to comment sensibly on it. Here is the "tickler": "Intratumor heterogeneity is a major obstacle in successfully eradicating tumors." In other words, tumors are (typically? -- all?) aggragates of differing cells. So, a drug -- or even a combo of drugs -- may only end up (after some time has passed) changing the population percentages. Tumor killing by high temperatures would not have this issue! -- a VERY wide spectrum of cells (ALL, I believe) are susceptible to death by high temperatures!

The above consideration augers VERY well for hyperthermia and ablation. More on this, later.